ATI Physical Therapy, Inc.
ATIP
$1.30
-$0.43-24.86%
| Weiss Ratings | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.77 | |||
| Price History | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.04% | |||
| 30-Day Total Return | 5.69% | |||
| 60-Day Total Return | 58.54% | |||
| 90-Day Total Return | -78.15% | |||
| Year to Date Total Return | -48.62% | |||
| 1-Year Total Return | -81.24% | |||
| 2-Year Total Return | -92.31% | |||
| 3-Year Total Return | -98.51% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -75.63% | |||
| 52-Week Low % Change | 321.95% | |||
| Price | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.10 | |||
| 52-Week Low Price | $0.41 | |||
| 52-Week Low Price (Date) | Dec 06, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.64M | |||
| Enterprise Value | 1.00B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -18.57 | |||
| Earnings Per Share Growth | -67.05% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.01 | |||
| Price/Book (Q) | -0.04 | |||
| Enterprise Value/Revenue (TTM) | 1.37 | |||
| Price | $1.30 | |||
| Enterprise Value/EBITDA (TTM) | 32.14 | |||
| Enterprise Value/EBIT | 265.03 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 630 296 2223 | |||
| Address | 790 Remington Boulevard Bolingbrook, IL 60440 | |||
| Website | www.atipt.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.51% | |||
| Profit Margin | -7.94% | |||
| Management Effectiveness | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.24% | |||
| Return on Equity | -- | |||
| Income Statement | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 665.29M | |||
| Total Revenue (TTM) | 728.11M | |||
| Revenue Per Share | $167.19 | |||
| Gross Profit (TTM) | 321.42M | |||
| EBITDA (TTM) | 31.14M | |||
| EBIT (TTM) | 3.78M | |||
| Net Income (TTM) | -57.82M | |||
| Net Income Avl. to Common (TTM) | -57.82M | |||
| Total Revenue Growth (Q YOY) | 6.30% | |||
| Earnings Growth (Q YOY) | -124.96% | |||
| EPS Diluted (TTM) | -18.57 | |||
| EPS Diluted Growth (Q YOY) | -112.22% | |||
| Balance Sheet | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 23.46M | |||
| Cash Per Share (Q) | $5.39 | |||
| Total Current Assets (Q) | 160.32M | |||
| Total Preferred Equity (Q) | 238.87 | |||
| Total Equity (Q) | 77.73M | |||
| Current Ratio (Q) | 1.116 | |||
| Book Value Per Share (Q) | -$39.20 | |||
| Total Assets (Q) | 967.28M | |||
| Total Current Liabilities (Q) | 143.66M | |||
| Total Debt (Q) | 772.83M | |||
| Total Liabilities (Q) | 889.55M | |||
| Total Common Equity (Q) | -166.01M | |||
| Cash Flow | ATIP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.46M | |||
| Cash from Financing (TTM) | 41.18M | |||
| Net Change in Cash (TTM) | 3.73M | |||
| Levered Free Cash Flow (TTM) | -7.31M | |||
| Cash from Operations (TTM) | -25.99M | |||
